At CFO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top California based CFO’ operating in the Health Care space. If you think a CFO’ is missing from this list, feel free to contact our editor on [email protected].
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Erica Moore
CFO of Goop
CFO at goop.com
Follow Erica Moore:
About Goop: Goop is a lifestyle brand providing digital content and commerce.
Sean Brecker
Chief Financial Officer & Board Member of Headspace
CFO & Board at Headspace.
Follow Sean Brecker:
About Headspace: Headspace is a digital health platform that provides guided meditation sessions and mindfulness training.
Matthew De Dominicis
Partner & Chief Financial Officer of Norwest Venture Partners
Matt has more than 16 years of experience in financial management. As Norwest’s Chief Financial Officer, he oversees the firm’s financial operations. Before joining Norwest, Matt was the Chief Financial Officer at Watershed Asset Management, an SEC-registered investment adviser. At Watershed, Matt was responsible for the diverse business operations of the firm, managing over $1 billion across multiple hedge funds. Prior to that, he was fund controller at Highland Capital Partners, where he was part of a team responsible for the finance function for multiple venture capital and private equity funds. Matt previously held positions at Sowood Capital Management, Liberty Mutual Group, and Ernst & Young. Matt holds a BBA with a major in accounting from the Mendoza College of Business Administration at the University of Notre Dame, and an MBA from the University of Massachusetts, Boston. Matt is a certified public accountant.
Follow Matthew De Dominicis:
About Norwest Venture Partners: Norwest is a global venture capital and growth equity investment firm that specializes in venture and growth equity companies.
Christine A. Tsingos
EVP & CFO of Bio-Rad Laboratories
Ms. Christine A. Tsingos is Chief Financial Officer, Executive Vice President of Bio Rad Laboratories Inc. Previously, she was the Chief Operating Officer and Chief Financial Officer at Attest Systems, Inc., a provider of information technology asset discovery and management tools, from August 2002 to November 2002. Prior to that, Ms. Tsingos was a consultant to Attest Systems, Inc. from October 2000 to July 2002. She was the Chief Financial Officer at Tavolo, Inc., an online retailer of gourmet cookware and food, from November 1999 to September 2000, and she was Treasurer, and later Vice President and Treasurer, of Autodesk, Inc., a developer of design software, from May 1990 to November 1999.
Follow Christine A. Tsingos:
About Bio-Rad Laboratories: Bio-Rad Laboratories has played a leading role in the advancement of scientific discovery for over 50 years by providing a broad range of
Leon Rodriguez
Co-founder & CFO of NecesitoDoc
Co-founder & CFO of NecesitoDoc, prior experience in private equity at BK Partners and Mira Companies, Berkeley-Haas MBA
Follow Leon Rodriguez:
About NecesitoDoc: NecesitoDoc is a telehealth platform that delivers on-demand healthcare via video consultations.
Joe Selsavage
CFO of Lemonaid Health
Follow Joe Selsavage:
About Lemonaid Health, Metromile: Lemonaid Health is a telemedicine platform that uses technology to change the way people interact with health care.
Gene Castagnini
COO, CFO, CAO & Co-founder of Biocare Medical
Gene J. Castagnini, MS, MBA, co-founded Biocare Medical LLC in 1997 and serves as its Co-Owner and Chief Financial Officer. Gene Castagnini serves as the Chief Operating Officer and Executive Vice President of Biocare Medical, LLC Gene Castagnini served as the Chief Administrative Officer and Chief Financial Officer of BioGenex Laboratories. Inc., for 10 years. Gene Castagnini’s experience includes 15 years as a Director and Officer of Medi-Physics Inc., formerly a Hoffmann-La Roche Inc. subsidiary. Gene Castagnini has a BS in accounting and an MBA in Human Resource Management from the California State University school systems.
Follow Gene Castagnini:
About Biocare Medical: Biocare Medical is a provider of immunohistochemistry instrumentation.
Gerard van Hamel Platerink
Chief Financial Officer of Genalyte
Board Member at HealthMine, MedAvail Technologies & Genalyte.
Follow Gerard van Hamel Platerink:
About Accuitive Medical Ventures, Genalyte, Redmile Group: Genalyte is a life sciences company developing and commercializing innovative next-generation multiplexing technology.
Mimi Kwan
Chief Financial Officer of Spire Health
Mimi Kwan is the Chief Financial Officer of Spire Health.
Follow Mimi Kwan:
About Spire Health: Spire Health is the market leader in continuous respiration sensing and high-adherence, patient-friendly ambulatory monitoring.
Shaun Holt
CFO of Berkeley Lights
Shaun joined Berkeley Lights in November 2015 and was appointed Chief Financial Officer in March 2016. Prior to becoming CFO, Shaun was Vice President of Finance. Prior to joining Berkeley Lights, Shaun spent 7 ½ years at Illumina, Inc. heading up various aspects of their Finance organization. His roles included Sr. Director, Global Head of R&D and Business Unit Finance, EMEA Head of Finance, Accounting and Facilities, and Commercial FP&A. He earned a B.S. in Finance from California State University, Stanislaus.
Follow Shaun Holt:
About Berkeley Lights: Berkeley Lights is a provider of research and development services using micro-droplet technology that change the biological processes.
Hiep Pham
CFO of Clever Care Health Plan Inc.
Hiep Pham is the CFO at Clever Care Health Plan.
Follow Hiep Pham:
About Clever Care Health Plan Inc.: Clever Care Health Plan is a healthcare company that offers medicare advantage health plans to its members.
Georgia Erbez
Chief Financial Officer of Harpoon Therapeutics
Georgia Erbez currently works as the Chief Financial Officer for Harpoon Therapeutics. She previously worked at Artelo Biosciences, Inc. as the Member Board Of Directors.
Follow Georgia Erbez:
About Harpoon Therapeutics: Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.
George Radman
Co-Founder & CFO of Vivoo
Follow George Radman:
About Vivoo: Vivoo is a wellness assistant that provides custom nutrition advice to the users based on their urine sample analysis.
David Sachs
Chief Financial Officer of ImmunityBio
In July 2019, ImmunityBio hired David Sachs as its Chief Financial Officer. As a finance, private equity, venture capital, and investment banking executive, he has over two decades of operational, development, and investing expertise. Sachs was formerly the CFO of various NantWorks companies, including NantHealth and Integrity Healthcare. He was also a principal and executive of NantCapital, where he sat on the investment committee. Sachs formerly worked as an investment banker for Bank of America Merrill Lynch and in senior operational roles at Abraxis BioScience and Celgene. He is now on the boards of Mox Networks, LLC, Packetfabric, Inc., and the Chan Soon-Shiong Medical Center at Windber. Sachs earned his MBA in Finance and Strategy from UCLA Anderson School of Management, as well as his BA in Economics from the University of California, Los Angeles.
Follow David Sachs:
About ImmunityBio, NantHealth: ImmunityBio is an offshoot of Soon-Shiong’s NantWorks conglomerate, developing molecular-level cell-based treatments for diseases.
Steven Schwen
Chief Financial Officer of Vensana Capital
Steve Schwen joined Split Rock Partners at the firm’s inception as Chief Financial Officer. He currently oversees the finance, accounting, operations and human resources activities of the firm. Prior to joining Split Rock Partners, Steve was Chief Financial Officer of St. Paul Venture Capital, which he joined in 1998. Before joining St. Paul Venture Capital, he spent four years in the audit practice of KPMG LLP. He provided audit and consulting services to both public and private financial services companies including investment companies, mutual funds, investment managers and investment banks. Steve became a licensed CPA in the state of Minnesota after earning a BA degree in business administration-accounting at the University of St. Thomas. He is a member of the American Institute of Certified Public Accountants and the Minnesota Society of Certified Public Accountants.
Follow Steven Schwen:
About Split Rock Partners, St. Paul Venture Capital, Vensana Capital: Vensana Capital is a venture capital investment firm that focuses on healthcare with breakthrough innovations in medical technology.
Howard Horn
CFO of Vir Biotechnology
Howard Horn is the Chief Financial Officer of VIR. Previously, he led the Financial Planning and Corporate Finance functions at Biogen. Prior to joining Biogen, he held positions of increasing responsibility and was focused on the life sciences as a consultant with McKinsey & Company and as an equity research analyst at UBS. Howard holds an M.B.A from the Wharton School of the University of Pennsylvania and a B.A in Economics from Princeton University.
Follow Howard Horn:
About Vir Biotechnology: Vir Biotechnology is a clinical-stage immunology company developing therapeutic products to treat and prevent serious infectious diseases.
Robin L. Praeger
CFO, Managing Director of Versant Ventures
Robin and his team have primary responsibility for Versant’s financial, legal, Investor Relations and administrative functions. Robin brings over twenty years of professional services and financial experience to Versant. Prior to joining Versant in 2000, Robin was a tax partner with Arthur Andersen, and has extensive experience in partnership formation and structuring issues. At Anderson his client base included large real estate partnerships and corporations. Robin received a Bachelor’s degree in Political Economics of Industrial Societies from the University of California, Berkeley, and a Master’s degree in Taxation from Golden Gate University. He is a Certified Public Accountant and a member of the AICPA and the California State Board of Accountancy. Robin currently sits on the Board of the West Coast Chapter of the Private Equity Chief Financial Officer Association and is a member of the NVCA CFO Task Force.
Follow Robin L. Praeger:
About Versant Ventures: Versant Ventures caters to the healthcare sector with early and later stage venture, private equity, and debt financing investments.
Spencer Lee
CFO of Hims & Hers
Follow Spencer Lee:
About Hims & Hers: Hims is a wellness brand that helps men and women get access to products for skin care, hair loss, and sexual health.
Kathryn E. Falberg
Executive Vice President and Chief Financial Officer of Jazz Pharmaceuticals
Kathryn Falberg was appointed our Executive Vice President and Chief Financial Officer in March 2012. She served as our Senior Vice President and Chief Financial Officer from 2009 to 2012. Her responsibilities include finance, strategy, corporate development and IT. From 1995 through 2001, Kathryn Falberg was with Amgen, Inc., where she served as Senior Vice President Finance, Strategy and Chief Financial Officer, and before that as Vice President, Controller and Chief Accounting Officer, and Vice President, Treasurer. From 2001 through 2008, Kathryn Falberg was President of Canyon Capital & Consulting, a private investment and consulting firm, where she worked with a number of smaller companies while also serving as a corporate director and audit committee chair for several companies. From February to November 2009, she was Chief Financial Officer and Chief Operating Officer at ARCA biopharma, Inc., a biopharmaceutical company. Kathryn Falberg received an M.B.A. and B.A. in Economics from the University of California, Los Angeles and is a Certified Public Accountant (inactive). Kathryn Falberg currently serves on the boards, and is chair of the audit committees, of biopharmaceutical companies Halozyme Therapeutics, Inc. and Medivation, Inc.
Follow Kathryn E. Falberg:
About Jazz Pharmaceuticals: Jazz Pharmaceuticals is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments.
James Hinrichs
Executive Vice President and Chief Financial Officer of Alere
James (“Jim”) Hinrichs joined Alere in April 2015 as Executive Vice President and Chief Financial Officer, with global responsibility for Finance, Accounting, Procurement, IT and Shared Services. Prior to his appointment as CFO of Alere, Jim Hinrichs was CFO at CareFusion Corp., a global medical technology corporation, since 2010. He held this position through the completion of Becton Dickinson’s acquisition of CareFusion in March 2015. Prior to this role, Hinrichs served as SVP of Global Customer Support and, before that, Corporate Controller of CareFusion. Previously, he was Executive Vice president and Controller of Cardinal Health, CFO of Cardinal Health’s Clinical and Medical Products segment and CFO of Cardinal Health’s Healthcare Supply Chain Services segment.. He joined Cardinal Health in February 2004, following 12 years of finance and marketing roles at Merck & Co. and two years as the CFO of SangStat Medical Corporation.
Follow James Hinrichs:
About Alere: Alere provides diagnostics and health management solutions for infectious, heart and cancer-related diseases and drug addicts.
Tobias Mezger
Co-Founder – COO/CFO of PayZen
I am passionate about solving big problems by making financial services more straightforward and more accessible. I am excited about building a great company.
Follow Tobias Mezger:
About PayZen: PayZen is a health care fintech startup that aims to tackle the growing patient payment responsibility problem.
Ken Myszkowski
Chief Financial Officer of Arrowhead Pharmaceuticals
Follow Ken Myszkowski:
About Arrowhead Pharmaceuticals: Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Rick Kent
CFO of Paramit Corporation
Rick Kent is the Chief Financial Officer at Paramit Corporation.
Follow Rick Kent:
About Paramit Corporation: Paramit designs and manufactures medical devices and life science instruments.
Tom LaRose
CFO of Paramit Corporation
Tom LaRose is CFO at Paramit Corporation.
Follow Tom LaRose:
About Paramit Corporation: Paramit designs and manufactures medical devices and life science instruments.
Denise Ferre
Partner, CFO of Moneta Ventures
Denise Ferre is a partner at Moneta Ventures and its CFO. Prior to joining Moneta Ventures, Denise was the CFO and co-founder at Sparta Consulting, a global IT consulting firm. She spearheaded the financial operations of the $100+ million company with over 1,500 employees. Besides the financial operations, Denise was also responsible for HR, IT and legal departments at Sparta . Before Sparta, Denise was the Business Unit Controller at Rapidgm, a global IT consulting firm, and later assumed the role of U.S. Controller when the firm was acquired by Fujitsu in 2006. Denise has a Bachelor’s Degree in Business Administration and Accounting.
Follow Denise Ferre:
About Moneta Ventures: Moneta Ventures is a venture capital firm that invests in early-stage technology and healthcare businesses.
Niall O’Cathasaigh
CFO of Prealize Health
As CFO, Niall O’Cathasaigh is the senior executive responsible for sound fiscal management of all financial operations and human resource activities, as well as overseeing capital raising efforts and financial reporting for board and other stakeholder communications. Niall has been working as a founder and consultant with startups and growth stage companies in the US, Europe and Africa for over 20 years. He works with Countsy, an innovative professional services firm that specializes in working with venture funded startups to provide end to end strategic and back office services. His experience includes work with over 30 startups in the Bay Area, with a focus on healthcare companies, providing financial transparency and strategic guidance as well as enabling funding rounds and acquisitions. Niall is also a founder and partner of ManoCap, a private equity fund management company that makes equity investments in small to mid-cap enterprises in West Africa. Prior to that he worked at Apple’s European divisions in Ireland and France. Niall is a qualified financial professional (CIMA). He holds a postgraduate degree in business from University College Dublin, and a joint BA in History and Classical Civilization from University College Galway and Universite De Poitiers.
Follow Niall O’Cathasaigh:
About Prealize Health: Prealize Health uses machine learning to transform healthcare from reactive to proactive.
David Cristman
Chief Financial Officer of ClearCare
Follow David Cristman:
About ClearCare, ClearCare: ClearCare is a web-based software solution that helps home care agencies efficiently focus on what’s important: providing better care.
Glenn S. Boehnlein
Chief Financial Officer & Vice President of Stryker
Follow Glenn S. Boehnlein:
About Stryker: Stryker is a medical technology company that offers products and services in orthopaedics.
Kim Witmer
Senior Vice President & Chief Financial Officer & Treasurer of Salk Institute for Biological Studies
Kim Witmer is Senior Vice President, Chief Financial Officer and Treasurer of the Salk Institute. She oversees all financial activities of the Salk, including financial reporting and treasury functions, research accounting, annual budgets, procurement, grants administration and endowment/investment management. Prior to joining the Salk, Witmer worked for the international accounting firm of Deloitte & Touche. Witmer also acts as past President of AIRI, the Association of Independent Research Institutes, as well as serving on AIRI’s Board of Directors and Government Affairs Committee. AIRI brings together nearly 100 independent, not-for-profit biomedical and behavioral research institutes whose mission is to enhance the ability of its members to improve human health and advance knowledge. Additionally, Witmer served as the Chief Financial Officer and Treasurer of the Sanford Consortium for Regenerative Medicine (SCRM), and currently holds a position on SCRM’s Administrative Council as the Salk representative. She is a Certified Public Accountant and holds a B.S. in business administration from San Diego State University.
Follow Kim Witmer:
About Salk Institute for Biological Studies: Salk Institute for Biological Studies conducts research on molecular biology and genetics, neurosciences, and plant biology.
Susan M. Kanaya
Senior Vice President, Finance, Chief Financial Officer and Secretary of ChemoCentryx
Ms. Susan M. Kanaya has served as our Senior Vice President, Finance, and Chief Financial Officer since January 2006, and Secretary since February 2006. Prior to joining us, Ms. Kanaya served as Senior Vice President, Finance, and Chief Financial Officer at Kosan Biosciences Inc., a biotechnology company, from 1999 to 2005. Prior to this, she served in financial management positions at SUGEN, Inc., a biotechnology company, from 1994 to 1999, most recently as Vice President, Finance, and Treasurer. Ms. Kanaya also served as Controller with high technology companies and as a public accountant with KPMG. Ms. Kanaya received her B.S. in business administration from the University of California, Berkeley.
Follow Susan M. Kanaya:
About ChemoCentryx: ChemoCentryx develops orally administered small molecule therapeutics that target chemokine receptors and related chemo-attractants.
Brian Jung
CFO of AiCure
Brian Jung is the CFO of AiCure.
Follow Brian Jung:
About AiCure: AiCure is an advanced data analytics company that uses artificial intelligence to understand how patients respond to treatments.
Shalini Sharp
CFO of Ultragenyx Pharmaceutical
Shalini Sharp joined Ultragenyx in May 2012 as Chief Financial Officer and Senior Vice President, Finance. She is a member of the Senior Management Team and is responsible for leading the corporate finance function, including strategic financial planning, accounting, budgeting and forecasting, financial analysis, general risk analysis, and financing activities. Shalini Sharp is a member of the Board of Directors of Agenus Inc. (formerly Antigenics Inc.), a publicly traded biotechnology firm, where she served as Chief Financial Officer from 2006 to 2012. She joined Agenus in 2003 and held increasing roles of responsibility spanning strategic planning, corporate development, investor relations, corporate finance and business development. Prior to Agenus, Shalini Sharp held similar roles at Elan Pharmaceuticals from 1998 to 2003, including serving as chief of staff to the Chairman of the Board of Directors during that company’s restructing. With 16 years of industry experience, Shalini Sharp has spearheaded numerous financing and business development transactions that have been critical to the success of Agenus and Elan. Prior to Elan, Shalini Sharp was a management consultant at McKinsey & Company as well as an investment banker at Goldman Sachs, specializing in pharmaceuticals and medical devices.
Follow Shalini Sharp:
About Ultragenyx Pharmaceutical: Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Mike Heather
Chief Financial Officer of Prime Healthcare Services
Mike Heather has served as CFO for Prime Healthcare for three years. Mr. Heather previously served as CFO of Prospect Medical Holdings, where he led the company’s IPO in 2005 and oversaw all Finance Department functions, including internal and external financial reporting, regulatory reporting, debt compliance and reporting, investor relations, banking, treasury, and more. Prior to Prospect Medical Holdings, Mr. Heather served as CFO and then CEO of WEBVISION, INC. (now Demand Media), a developer/operator of internet data centers, internet domain names and eCommerce. Earlier in his career, he served as a healthcare practice leader and quickly rose through the ranks to partner at Deloitte & Touche, LLP. Mr. Heather earned his Bachelor of Commerce from Rhodes University. He served on the board and is active with C.A.S.A., a non-profit organization that helps abandoned and neglected children. Mr. Heather obtained his CPA certification both in California and internationally.
Follow Mike Heather:
About Prime Healthcare Services: Prime Healthcare Services provides hospital systems.
Bryan Giraudo
Chief Financial Officer & COO of Gossamer Bio
Mr. Giraudo is the Chief Financial Officer of Gossamer Bio. Previously, he was Senior Managing Director at LEERINK Partners, where he was responsible for LEERINK’s Western North America and Asia life sciences investment banking practice. Prior to joining LEERINK Partners in 2009, Bryan was a Managing Director in Merrill Lynch’s Global Healthcare Investment Banking Group. Bryan received his B.A. from Georgetown University.
Follow Bryan Giraudo:
About Gossamer Bio: Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.
Peter C. Wulff
Chief Financial Officer of JenaValve Technology
Peter C. Wulff is the chief financial officer of [JenaValve Technology](https://www.crunchbase.com/organization/jenavalve-technology#/entity), a provider of TAVI systems for transapical and transfemoral implantation. Prior to that, he was the chief financial officer and chief operating officer of Pure Bioscience. Before joining Pure Bioscience, Wulff served as the chief financial officer, vice president, and treasurer at Alphatec Spine. Previously, he was the executive vice president and chief financial officer of Artes Medical. He has also been employed at CryoCor, Ligand Pharmaceuticals, and IMED Corporation. Wulff holds a bachelor’s degree in economics and master’s degree in finance from Indiana University Bloomington. He resides in San Diego, California, United States.
Follow Peter C. Wulff:
About JenaValve Technology: JenaValve Technology develops transcatheter aortic valve implantation (TAVI) systems for transapical and transfemoral implantation.
Aaron Freidin
Chief Financial Officer of Grail
Aaron Freidin is Chief Financial Officer at Grail.
Follow Aaron Freidin:
About Grail: Grail develops a pan-cancer screening test designed to detect cancers at an early stage.
Lee Raymundo
CFO of Redox
Lee Raymundo is the CFO at Redox.
Follow Lee Raymundo:
About Redox: Redox is an EHR integration and healthcare platform that accelerates the development and distribution of healthcare software solutions.
Lisa Riedmiller
Chief Financial Officer of Wavemaker 360
Lisa Riedmiller is Chief Financial Officer for Siemer Ventures. She has over 24 years of venture capital fund accounting, investor relations and fund administration experience. Lisa successfully built her specialized venture capital accounting services business to target the niche market of smaller and developing funds by offering her clients high level financial support without the burden of full-time overhead. In addition to Siemer Ventures, Lisa’s current clients includes BioStar Ventures, Blade Ventures, Crosscut Ventures, Global Opportunities Fund, Millennium Life Sciences Fund, Okapi Ventures, Palomar Ventures, Rincon Ventures, Saratoga Ventures V & VI and Saratoga Ventures IV. Formerly, Lisa has worked with Capstone Ventures, Enterprise Partners, Ocean Park Ventures, and Windward Ventures. Additionally, she has been retained by a variety of start-ups as a function of her involvement with their investors. From 1988 to 1997, Lisa was employed by OSCCO Ventures, one of the first VCs to break ground at Sand Hill Road in Menlo Park, CA. Ms. Riedmiller holds a BA from California State University at San Jose, graduating Summa Cum Laude.
Follow Lisa Riedmiller:
About BioStar Capital, Crosscut Ventures, Palapa Ventures, Palomar Ventures, Rincon Venture Partners, Wavemaker 360: Wavemaker Three-Sixty Health is the leading U.S. early-stage (Seed and following on at the Series A) fund focused 100% on healthcare.
Jeff Pashalides
Chief Financial Officer of Nomi Health
Follow Jeff Pashalides:
About Nomi Health: Nomi Health is a direct health company that aims to reduce the cost of health care for employers and patients.
Randy Sieve
Chief Financial Officer of HydraFacial
Randy Sieve has served as chief financial officer for HydraFacial since March 2018. Prior to joining the company, Randy held the CFO position for Columbus Manufacturing. He has over 30 years of experience, serving in positions with companies such as Central Garden & Pet Company, Diageo PLC, The Blommer Chocolate Company, Nabisco Brands, and QVC Network.
Follow Randy Sieve:
About HydraFacial: HydraFacial is an FDA registered manufacturer of advanced aesthetic technologies and products.
Lauren Silvernail
CFO and EVP Corporate Development of Evolus
Lauren Silvernail is the Chief Financial Officer and Executive Vice President, Corporate Development at Evolus.
Follow Lauren Silvernail:
About Evolus: Evolus medical aesthetics focused on providing physicians and their patients with expanded choices in aesthetic procedures and treatments.
Vikram Bakhru
Chief Operating Officer & Chief Financial Officer of ConsejoSano
Dr. Vik Bakhru is a physician, senior healthcare executive and entrepreneur who has served in numerous executive roles in healthcare and business. He is currently the Chief Operating Officer at ConsejoSano, a leading venture-backed health technology platform that enables payers and providers to simplify care, increase engagement and lower costs. Previously, Dr. Bakhru was Chief Operating Officer of First Opinion, Inc. Before First Opinion, Inc., Dr. Bakhru served as Chief Medical Officer for Abercrombie & Kent Global Health, a Fortress Investment Group portfolio company that facilitates high quality, affordable medical travel. In addition, Dr. Bakhru worked as a Director at New York Presbyterian Hospital/The University Hospital of Columbia and Cornell in New York City where he managed an annual spend base of approximately $600 million for the purchase of all clinical goods and services. Prior to his role at NYP, Dr. Bakhru worked with the Foundation for International Medical Relief of Children (FIMRC), a non-profit he founded while completing his medical degree at The George Washington University School of Medicine & Health Sciences in Washington, DC. FIMRC (www.fimrc.org) is a 501(c)3 non-profit organization dedicated to providing health care access in underserved areas of the developing world through a network of health centers in nine countries across 12 project sites. FIMRC now boasts a team of over 3,000 full-time staff and volunteers. Dr. Bakhru serves on the Board of Directors for several organizations including the Nanubhai Education Foundation, Aspire Global Health and FIMRC. Dr. Bakhru’s professional affiliations include membership in the American College of Surgeons, the American Medical Association and the American Telemedicine Association. He has been practicing medicine since 2007 and is currently a licensed physician in 17 states (AZ, CA, DC, FL, GA, IL, MA, MD, MI, NC, NY, OH, PA, UT, VA, WA, WI). He is clinically active as a private practitioner and as an on-call physician at UCSF Medical Center and Main Line Health. Dr. Bakhru earned a Bachelor of Arts in Economics and a Bachelor of Science in Biology from The George Washington University as part of the Seven-Year Integrated Medical Program. After his undergraduate and medical education in Washington, DC, Dr. Bakhru did residency training in general surgery in Philadelphia and subsequently earned a Master of Business Administration degree in Health Care Management from The Wharton School of the University of Pennsylvania. Recognitions include the American Medical Association Foundation Excellence in Leadership Award, The George Washington University Award, the Kaiser Family Foundation Grant, the Becker’s Hospital Review: Rising Stars in Healthcare Award, and most recently was named to the Wharton Forty Under Forty for 2017. Dr. Bakhru gives over a dozen keynote speeches and participates in numerous panel discussions per year. His topics include clinical medicine, digital health, entrepreneurship, global health, innovation, leadership, Medicaid/Medicare, patient engagement, product development & technology, social determinants of health, robotics, and user experience. He has presented at the Indian Institute of Management, HIMSS Precision Medicine Summit, Stanford Medicine X, HIMSS Pop Health Forum, 7th Digital Health London, HIMSS Digital & Personal Health Forum, UCLA Anderson Healthcare Conference, Entrepreneur’s Summit, MIT Sloan Healthcare & Bioinnovation Conference, Ayusmat Healthcare Leadership Summit and The Wharton School, University of Pennsylvania (Philadelphia, Pennsylvania).
Follow Vikram Bakhru:
About ConsejoSano, First Opinion Medical Services, Mir Ventures: Multicultural engagement and navigation solutions
John Alves
SVFG CFO of VeriSIM Life
As CFO, John J. Alves brings more than 25 years of high-tech software and finance experience to Accela. Mr. Alves has significant experience at both public and private companies with expertise in high-growth enterprise software environments. At the senior management level, Mr. Alves has been involved in 2 successful IPOs, a private equity transaction and numerous mergers, acquisitions and public debt offerings. Mr. Alves is responsible for Accela’s worldwide finance organization and building a finance infrastructure to support a high-growth environment. Prior to joining the Accela team, Mr. Alves most recently served as Interim Chief Financial Officer and Vice President of Finance for Serena, Inc., the largest global independent software company solely focused on managing change and processes across IT environments, where he was responsible for managing its worldwide finance organization. Prior to that, Mr. Alves held various senior management positions with the Company. Before Serena, Inc., Mr. Alves was Vice President of Finance for Barra Inc., which was subsequently acquired by MSCI, a leading provider of investment decision support tools of which Barra is a leading brand. Mr. Alves’ experience also includes three years with a regional CPA firm in Northern California where he was a senior audit manager in the firm’s professional services practice. Mr. Alves is a Certified Public Accountant and holds Bachelor of Science and Master of Business Administration degrees in Finance and Accounting from California State University, East Bay.
Follow John Alves:
About 3T Biosciences, Advanced Rx Management, VeriSIM Life: VeriSIM Life is a computational bioplatform that predicts the clinical outcomes of new drugs before clinical trials.
Leo Popov
Founder, CFO, Product & Growth TrueCare24 | 500 Startups Batch 20 Company of TrueCare24
CEO & Co-Founder of TrueCare24.
Follow Leo Popov:
About TrueCare24: In-Home Senior Care Automation Platform
Paul Manners
Chief Financial Officer of Trak
Follow Paul Manners:
About Trak: Sandstone Diagnostics provides an integrated wellness technology that empowers consumers to measure, monitor, and improve their health.
Bradley E Schmidt
Co-Founder & Chief Financial Officer of Smile Brands
Brad Schmidt is Chief Financial Officer at OneSmile, LLC, and Smile Brands Inc. (SBI). Brad co-founded OneSmile in 2015 and was with Smile Brands from 1998 through 2013, initially serving as Vice President and Controller through 2002, then subsequently as Chief Financial Officer for over a decade. While under Brad’s financial leadership, Smile Brands grew from a start-up to the largest dental support organization (DSO) in the United States, serving approximately 400 dental practices with annual revenues greater than $500 million. In supporting the company’s growth, Brad played a leading role in the integration of the company’s three initial platform acquisitions and Smile Brands’ subsequent acquisitions of Monarch Dental Corporation and Castle Dental Centers Inc. He also oversaw the company’s initial de novo expansion efforts, which led to the successful development of more than 150 practices.
Follow Bradley E Schmidt:
About OneSmile, Smile Brands: Smile Brands offers dentists and their patients numerous benefits and advantages over traditional dental care models.
John Maley
Chief Financial Officer of AliveCor
Follow John Maley:
About AliveCor: AliveCor is a FDA-cleared mobile heart solution that helps save lives, save money, and brings healthcare into the 21st century.
Cheryl Kim
Chief Financial Officer of Hazel Health
Cheryl Kim is the Chief Financial Officer at Hazel Health.
Follow Cheryl Kim:
About Hazel Health: Hazel Health is a healthcare company that improves the health and well-being of students by increasing access to healthcare.
Laura Francis
Chief Financial Officer of SI-BONE
Laura A. Francis has served as our Chief Financial Officer since May 2015. Prior to joining SI BONE, Ms. Francis was the Chief Financial Officer for Auxogyn, Inc., a women’s health company, from December 2012 to September 2014. From September 2004 to December 2012, Ms. Francis served as Vice President of Finance, Chief Financial Officer and Treasurer for Promega Corporation, a life science reagent company. From March 2002 to September 2004, Ms. Francis served as the Chief Financial Officer of Bruker BioSciences Corporation, a public life science instrumentation company. From May 2001 to March 2002, Ms. Francis served as Chief Operating Officer and Chief Financial Officer of Nutra-Park Inc., an agricultural biotechnology company. From April 1999 to May 2001, Ms. Francis was Chief Financial Officer of Hypercosm, Inc., a software company. From October 1995 to April 1999, Ms. Francis was an engagement manager with McKinsey & Company, a consulting firm. Early in her career, Ms. Francis was an audit manager with Coopers & Lybrand, an accounting firm. Ms. Francis received a B.B.A. from the University of Wisconsin and an M.B.A. from Stanford University. She is a Certified Public Accountant (inactive) in the State of California.
Follow Laura Francis:
About SI-BONE: SI-BONE advances the diagnostic understanding of lower back pain and minimally invasive surgery for the sacroiliac joint.
Brian Chudleigh
CFO of mPulse Mobile
Due to his over 15 years of experience in the healthcare sector, Brian not only manages the financial aspect of mPulse, but also contributes his expertise in healthcare operations towards our product development and market strategy.
Follow Brian Chudleigh:
About mPulse Mobile: mPulse Mobile, the leader in mobile health engagement, drives improved health outcomes and efficiencies by activating healthcare consumers
Nathan Weems
Chief Financial Officer of VitalConnect
Nathan has accrued over 13 years of operational excellence in management roles spanning finance, business development, and marketing, most recently serving as Sr. Director of Finance at Natera, a public Bay Area biotech company. Earlier experience includes tenure at a top Wall Street investment bank and Big-4 accounting firm. Nathan brings expertise in accounting, due diligence, market research, fund raising and investor relations. He holds a BA from the University of Southern California and an MBA from Wharton. When his HP 12C is not within reach, you can usually find Nathan on two wheels or two skis exploring the outdoors with his family.
Follow Nathan Weems:
About VitalConnect: VitalConnect is a wearable biosensor technology for wireless hospital and remote patient monitoring.
Eugenio Garcia
CFO of Innit
Follow Eugenio Garcia:
About Innit: Innit is an “eating technology” company that has developed the world’s first Connected Food Platform.
Jonathan Tu
CFO & Co-Founder of Fluxergy
Jonathan Tu is the Chief Financial Officer and Co-Founder at Fluxergy.
Follow Jonathan Tu:
About Fluxergy: Fluxergy is a biotechnology company that offers point-of-care testing, PCR, and medical diagnostics.
Mario Wanderley
Chief Financial Officer of Entrinsic Bioscience
Mario Wanderley is Managing Partner at VGP – Venture Growth Partners.
Follow Mario Wanderley:
About CitizenGlobal, Entrinsic Bioscience, Venture Growth Partners: Entrinsic Bioscience leverages gold standard science and game-changing amino acid technology.
Raj Matthew
Chief Financial Officer of Doctor Direct
Raised $1.2BB in public/private placements and negotiated over $1.3BB in transactions at Asante Technologies, PeopleWeb Communications and Vivato Networks. As CFO for Asante Technologies exceeded analyst expectations on turnaround plan while tripling analyst coverage. As CFO, led IPO process at PeopleWeb Communications, positioned company to analysts and investment bankers. Part of senior finance team that led the spin-off of PacTel Corporation, (Vodafone Airtouch) in the 4th largest IPO in US history, concurrent with a billion dollar debt offering. As VP Finance & Controller, led M&A team that managed a total of 10 mergers/acquisitions (4 public, 6 private companies) in 26 months at Avant!-Synopsys, while company grew to 42 offices in 16 countries, over 1000 employees, annual bookings in excess of $400 MM. Arranged $700MM in syndicated financing and refinanced $250MM in convertible bonds at Conner-Seagate during explosive growth, (reached $1.2BB in revenue in 13 months).
Follow Raj Matthew:
About Doctor Direct: Doctor Direct is an exciting company in the rapidly expanding Healthcare – remote patient monitoring space.
David Pool
Chief Financial Officer of Ocunexus Therapeutics
Mr. Pool joined CoDa Therapeutics as Chief Financial Officer in July 2008. He has over 20 years investment banking and venture capital experience including privatization transactions, leasing, securitizations, venture capital raising and initial public offerings. Mr. Pool has raised over $50M for early stage Biotech companies. Mr. Pool’s responsibilities include all financial and accounting functions as well as driving CoDa’s fund raising process and business development activities. Prior to CoDa, Mr. Pool was Protemix Corporation’s Chief Operating and Financial Officer for 5 years. Mr. Pool holds a Bachelor of Commerce in accounting and business administration from the University of Canterbury and is a member of the Institute of Chartered Accountants of New Zealand.
Follow David Pool:
About Inflammx Therapeutics, Ocunexus Therapeutics: Ocunexus Therapeutics is a biopharmaceutical company that develops therapeutics for unmet clinical needs in ophthalmology.
Tom O’Neil
Chief Financial Officer of Protagonist Therapeutics
Tom O’Neil is the chief financial officer of [Arcadia Biosciences](https://www.crunchbase.com/organization/arcadia-biosciences#/entity), an agricultural technology company focused on developing products that benefit the environment and human health. Prior to that, he held the same position at Sorbent Therapeutics. O’Neil has also served as the vice president of finance and marketing at ChemGenex Pharmaceuticals and as a team member at HX Diagnostics. O’Neil holds a bachelor’s degree in international relations from Pomona College and master’s degree in business administration from the University of California, Los Angeles. He lives in San Francisco, California, United States.
Follow Tom O’Neil:
About Nodality, Protagonist Therapeutics: Protagonist Therapeutics develops orally-stable peptides to treat diseases that are currently addressed by injectable antibodies.
Christopher Senner
Executive Vice President and Chief Financial Officer of Exelixis
Chris Senner is Executive Vice President and Chief Financial Officer at Exelixis. Since July 2015, Mr. Senner has held this role with responsibility for ensuring the prudent management of the company’s assets, allowing Exelixis to invest in its proprietary and partnered molecules, launch new indications and otherwise advance its important work in the treatment of cancer. Prior to joining Exelixis, Mr. Senner served as Vice President, Corporate Finance at Gilead Sciences, Inc., which he joined in March 2010. At Gilead, he was accountable for controllership, tax, treasury and corporate and operational financial planning. Before joining Gilead, Mr. Senner spent 18 years at Wyeth in a variety of financial roles with increasing responsibility, most notably as Chief Financial Officer of Wyeth’s U.S. pharmaceuticals business and the BioPharma business unit. Mr. Senner holds a B.S. in Finance from Bentley College.
Follow Christopher Senner:
About Exelixis: Exelixis works is focused on discovering, developing and commercializing therapies for the treatment of cancer and other serious diseases.
Evan Willette
Chief Financial Officer of Independent Living Systems
Evan Willette is the Chief Financial Officer (CFO) for Independent Living Systems (ILS). He manages all financial operations, planning, and analysis for ILS.Evan has over 25 years of experience is his field. He has consulted on IPO engagements, and is a member of the CFA Institute. Prior to joining ILS, Evan spent 14 years with Health Net as CFO of their Medi-Cal program, and VP of Finance for their Government Business Division encompassing their Medicaid and Medicare programs with over $5 billion of annual revenues. In this role, Evan was also responsible for developing financial strategy and plans for Health Net’s participation in the Dual Eligible Demonstration, Managed Long Term Support Services, and Medicaid Expansion.Evan received his Bachelor of Arts from Brandeis University, and his Master of Business Administration from the Graduate School of Business at the University of Chicago.
Follow Evan Willette:
About Health Net, Independent Living Systems: Independent Living Systems is a health service company that develops, delivers, and manages community-based services.
Ivan Ivankovich
CFO of Sanguine
Co-Founder of Full Stack Finance.
Follow Ivan Ivankovich:
About Full Stack Finance, LLC, Markaaz, Sanguine: Sanguine develops innovative technology solutions for clinical researchers.
Bing Zhu
CFO of Crown Bioscience
Mr. Bing Zhu is responsible for overseeing our corporate finance and IT departments. From 2010 to 2013, Mr. Zhu was the chief strategy officer of LDK Solar Co., Ltd., a company listed on the New York Stock Exchange, and concurrently an executive director and the chief financial officer of LDK Silicon & Chemicals Technology Co., Ltd., a subsidiary majority owned by LDK Solar Co., Ltd. From 2008 to 2010, Mr. Zhu was the chief financial officer and a director of Chemspec International Ltd., a company listed on the New York Stock Exchange. From 2005 to 2008, Mr. Zhu was with Canadian Solar Inc., whose head office is based in Suzhou, China, as a director and the chief financial officer. Prior to that, Mr. Zhu worked for four years in commercial banking in Toronto, Canada. From 1996 to 2000, Mr. Zhu was the Shanghai chief representative of Raytheon Corporation. From 1993 to 1996, Mr. Zhu was a corporate banking account manager for Banque Indosuez. Mr. Zhu holds a master of business administration degree from China Europe International Business School and a bachelor’s degree in business management from Zhejiang University of Technology in China.
Follow Bing Zhu:
About Crown Bioscience: CrownBio is helping provide clarity of action in the fight against cancer and diabetes.
McDavid Stilwell
Chief Financial Officer of Coherus Biosciences
McDavid Stilwell is the Chief Financial Officer at Coherus BioSciences.
Follow McDavid Stilwell:
About Coherus Biosciences: Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.
Jeffrey H. Cooper
Chief Financial Officer of Humanigen
Follow Jeffrey H. Cooper:
About Humanigen, Sierra Oncology: Humanigen is a biopharmaceutical company that focuses on developing human antibody therapeutics.
Cameron Durrant
Chairman, CEO and Interim CFO of Humanigen
Follow Cameron Durrant:
About Humanigen: Humanigen is a biopharmaceutical company that focuses on developing human antibody therapeutics.
Lakshmi Prathipati
Chief Financial Officer of EHR Your Way
Follow Lakshmi Prathipati:
About EHR Your Way: EHR Software Your Way is a unique Electronic Health Records System.
Jay File
Chief Financial Officer of Evofem Biosciences
Jay File has served as our Chief Financial Officer at Evofem Biosciences since 2015. He has approximately 25 years of diverse accounting and finance experience within a variety of both public and private biotechnology companies. Most recently, he provided executive financial and accounting oversight services to various biotechnology companies in San Diego, assisting in their initial public offering process and helping to establish and improve their accounting and finance operations as publicly-traded entities. Prior to this, Mr. File was Senior Director and Controller of Sequenom, Inc, a diagnostic company that developed and commercialized molecular diagnostics testing services for the women’s health market. During that time, he served as Treasurer of their diagnostic subsidiary and providing assistance in the raise of over $400 million in combined equity and convertible note offerings. He also assisted in the commercial launch of four diagnostic tests in a two-year period, which included Sequenom’s revolutionary noninvasive prenatal test for Down syndrome. Earlier in his career he worked for approximately ten years in public accounting, primarily with Arthur Andersen LLP, where he worked with a variety of clients assisting with attestation and periodic reporting requirements, public offerings and acquisitions. He graduated from Central Washington University with a Bachelor’s of Science in Accounting and International Business and is a Certified Public Accountant (inactive).
Follow Jay File:
About Evofem Biosciences, WCG Cares: Evofem is a biotechnology company that develops reproductive and contraceptive care products for women worldwide.
Dan T. Bessey
CFO of Thermogenesis
Follow Dan T. Bessey:
About Thermogenesis: Thermogenesis, a health care company, focuses in development of automated technologies for cell-based therapeutics and bioprocessing.
Matteo Marchetta
CFO of Augmedix
Matteo comes to Altiscale from Exigen Capital, where he was the operating partner leading finance in early and growth-stage SaaS portfolio companies. Previously, as CFO he led the turnaround and growth of Tie Rack and Rolling Luggage group, a multinational retailer based in London. His background is in consulting with Boston Consulting Group, where he delivered growth strategies for large corporations in the IT and retail markets and as an engineer in the telecommunications industry. He holds an MBA from IESE Business School in Barcelona and a master’s in electronic engineering with a specialization in computer science.
Follow Matteo Marchetta:
About Altiscale, Augmedix: Augmedix is a tech-enabled service that allows doctors to focus on what matters most: patient care.
Andrew Ruff
CFO of Liquid Grids
Andrew Ruff brings a wealth of managerial accounting experience to LiquidGrids. With experience as a Principal of TGG Accounting, Chief Executive Officer at The Garrett Group and Controller in the U.S. Marine Corps, Mr. Ruff leads LiquidGrids non-core business functions including accounting, human resources, compliance, risk mitigation and facilities. The integration of key performance metrics and financial reporting within all of LiquidGrids operations is Mr. Ruff’s primary focus of effort. Mr. Ruff has led multiple companies through successful start-ups, capital raises, operating cycles and exits. Mr. Ruff’s academic background includes a B.S. in Economics from the United States Naval Academy, where he graduated as the Brigade Executive Officer.
Follow Andrew Ruff:
About Gastronome Ventures, Liquid Grids, TGG Accounting, TGG Accounting: Liquid Grids empowers healthcare companies to listen, understand, and strategically engage in online health dialogues.
Bruce Burlington
Chief Financial Officer of LifePlus
Bruce Burlington is a Chief Financial Officer at LifePlus.
Follow Bruce Burlington:
About LifePlus: LifePlus is a health startup developing a disruptive deep health technology solution.
Michael Watts
Chief Financial Officer of Sonendo
Michael brings over 20 years of experience within the medical device and healthcare industries. Prior to joining Sonendo, Michael was the Chief Financial Officer of The HydraFacial Company, a leading manufacturer and marketer of non-invasive equipment and consumables used in aesthetic skin health treatments. Michael has held senior financial leadership positions within Johnson & Johnson, Zimmer Holdings and Danaher Corporation. Early in his career, he spent five years as an auditor in public accounting and is a Certified Public Accountant (Massachusetts). Michael holds a Bachelor of Science degree in Accounting from the University of Massachusetts and Master of Science from Bentley College.
Follow Michael Watts:
About Sonendo: Sonendo is a developing innovative and disruptive technologies to transform endodontic therapy.
John Bostjancic
Chief Financial Officer of SeaSpine
John Bostjancic serves as our chief financial officer and treasurer. Prior to joining SeaSpine, Mr. Bostjancic was senior vice president of global supply chain at Integra LifeSciences from 2012 to 2014 where he was responsible for global planning, kitting, distribution, logistics and customer service functions and led the project team to comply with the FDA’s UDI rule in 2014. From 2008 to 2012, Mr. Bostjancic was senior vice president of Integra’s Financial Planning & Analysis organization. Mr. Bostjancic joined Integra in 1999 and held roles of increasing responsibility in the finance organization, including corporate controller from 2003 to 2006. Before joining Integra, Mr. Bostjancic was a manager in the Accounting Standards team at Merck & Co. Inc. and worked in the Business Assurance organization at PricewaterhouseCoopers. He received a B.A. in accounting from the College of New Jersey.
Follow John Bostjancic:
About SeaSpine: SeaSpine is a medical technology company offering spinal disorder solutions.
John Beck
Acting Chief Financial Officer of AEGEA Medical
John started BeckCFO in 2007 and brings over 30 years of experience in financial management, strategic planning and execution for technology firms. John has worked with early stage companies in life sciences (medical device and pharmaceutical), fabless semiconductor, software and software as a service, hardware systems, and services. John has held full-time CFO positions with both public and private companies, and, in addition to finance, has broad experience managing cross-functional areas such as IP management, legal, treasury, risk management, HR, IT and facilities. John’s background also includes managing the accounting, finance and reporting requirements of European and Asian offices. Before starting BeckCFO, John previously served as CFO for several companies including: Silicon Bandwidth, Inc., nDSP Corporation (acquired by PixelWorks), Sigma Designs, Inc., Augeo Software, Meta-Software, Inc. (acquired by Synopsys), Sellectek Incorporated, RayLAN Corporation, Optimem and Spectra Logic subsidiaries of Cipher Data Products, and Minton Company. Prior to his tenure at technology firms, John held senior audit positions at Ernst & Young and KPMG Peat Marwick certified public accounting firms. John earned a B.S. degree in Commerce with an Accounting emphasis, cum laude, from Santa Clara University. He is also a licensed C.P.A. (inactive), with the State of California.
Follow John Beck:
About AEGEA Medical, CloudPhysics: AEGEA Medical manufactures surgical and medical instruments.
Scott Gorton
CFO of Apton Biosystems
Follow Scott Gorton:
About Apton Biosystems, Cloudleaf, Precursor Energetics: Apton Biosystems develops a high-throughput and low-cost sequencing platform that revolutionizes the availability of genetic analysis.
Paul Anthony
Chief Financial Officer and Corporate Secretary of Auxilio, Inc.
Paul joined Auxilio in 2005 as Chief Finanical Officer and Corporate Secretary. Paul is a Certified Public Accountant and an expert in financial management, investor relations, tax, treasury and risk management with over 20 years of professional services experience with worldwide enterprises, publicly traded companies and start-ups. His career has included time with KPMG Peat Marwick LLP and IBM. Paul Anthony earned a Bachelor of Science degree in accounting from Northern Illinois University.
Follow Paul Anthony:
About Auxilio, Inc.: Provides comprehensive managed print, data security, IT risk and process development services for health care enterprises
Reynold Samoranos
Chief Financial Officer of PX6 Medical Systems
Mr. Samoranos has been a Chief Financial Officer since 1991. He is recognized for his domestic and global leadership in financial, operational, investments, and strategic business management. He recently worked at CFO COO Consultants, Inc. as a CFO Management Consultant, working with start-ups, non-profits, private companies, and the government. Before CFO COO Consultants, Reynold worked for various institutional Investment Firms as the Chief Financial Officer, COO, and CCO, including – Hanson Investment Management Company, a $2.5 Billion domestic equity firm, Newport Pacific Management Company, a $3.0 billion international investment firm, and Hammerman Capital Management, LLC, an Opportunity hedge fund. Reynold received his bachelor’s of science degree in Business Administration from the Haas Business School at the University of California, Berkeley, and an MBA in finance and international business from the Booth Business School at the University of Chicago.
Follow Reynold Samoranos:
About PX6 Medical Systems: A CONTEMPORARY “LOGISTICS” FOR 21ST-CENTURY HEALTHCARE.”
Jeannie Yoo
Chief Financial Officer of Prospective Payment Specialists
Jeannie brings 18 years of experience working as a Controller and Operations Manager for a variety of companies. Jeannie’s broad knowledge of IT, IS and General Finance enables her to perform both as CFO and Director of IT/IS and HR for PPS. Her efficiency enhanced workflow process and ensures the smooth operation of all administrative functions. Jeannie is always looking for improvement and lean processes to make daily work life easier for PPS team. She puts high importance on team work.
Follow Jeannie Yoo:
About Prospective Payment Specialists: PPS provides compliance-based coding and revenue cycle management solutions to the largest hospital systems, regional medical centers.
Ingrid Safranek
CFO of MMRGlobal
Ingrid Safranek has been a Certified Public Accountant in California since 2006. She worked for Deloitte & Touche from 2002 to 2006, where she was part of the audit teams for large and small, private and public clients such as Computer Sciences Corporation, Infonet (later acquired by British Telecom), Candle! Corporation (later acquired by IBM), Primedia, Inc., Gold Circle Entertainment, and the Performing Arts Center, among others. Her focus was on the technology, media and entertainment industries. She is also the owner of Goldstein Enterprises, a management consulting firm that has served numerous clients by providing them with business practices analyses and software application development in order to streamline day-to-day operations and maximize efficiency. Among her past and current clients as owner of Goldstein Enterprises are Nestle USA, Warner Bros. Studios and RJR Fashion Fabrics. Ingrid Safranek received a B.A. in Business Economics with a minor in Accounting from UCLA.
Follow Ingrid Safranek:
About MMRGlobal: MMRGlobal provides secure, easy-to-use multilingual personal health records (PHRs) and electronic safe deposit box storage solutions.
Graham Cooper
COO, CFO of Assembly Biosciences
Graham Cooper joined us as Chief Financial Officer in February 2013. Prior to joining us, during 2012, Graham Cooper was the Executive Vice President, Finance and Chief Financial Officer of Geron Corporation, a biopharmaceutical company focused on cancer therapies. From 2006 until 2011, Graham Cooper served as Senior Vice President, Chief Financial Officer and Treasurer of Orexigen Therapeutics, Inc., a biotechnology company focused on obesity. From 1999 to 2006, Graham Cooper held positions of increasing responsibility including Director, Health Care Investment Banking, at Deutsche Bank Securities, where he was responsible for executing and managing a wide variety of financing and merger and acquisition transactions in the life sciences field. From August 1992 to January 1995, he worked as an accountant at Deloitte & Touche, and was previously a C.P.A. Graham Cooper holds a B.A. in Economics from the University of California at Berkeley and an M.B.A. from the Stanford Graduate School of Business.
Follow Graham Cooper:
About Assembly Biosciences, Beam Therapeutics: Assembly Biosciences, Inc. is a public biotechnology company and provider of oral biologic therapeutics.
David Voris
CFO of Shifamed
David joined Supira Medical as Chief Financial Officer in January of 2019 and serves as the CFO for each of Shifamed’s portfolio companies. He brings over 25 years of experience in financial and operating executive leadership roles for early-stage and mid-sized medical device and life science companies. His experience includes a significant number of equity, debt, and shareholder liquidity transactions, the establishment and oversight of financial and operating controls and information systems that enable rapid scaling, and direct operational accountability. Most recently David served as CFO and COO of Optovue, Inc. a medical device company that rapidly emerged as a leader in Ophthalmology imaging. David also served as CFO for Laser Diagnostic Technologies up until its sale to Carl Zeiss Meditech. David is a certified public accountant and began his career at Deloitte in the Emerging Business Services group.
Follow David Voris:
About Atia Vision, Shifamed, Supira Medical: Shifamed is a progressive medical technology incubator that combines human-centered design.
Scott Giacobello
Chief Financial Officer of GW Pharmaceuticals
Scott Giacobello brings 25 years of finance and operational experience to GW Pharmaceuticals.He is an accomplished executive who most recently and until its acquisition by Allergan, Inc. in late 2016, served as Chief Financial Officer for Chase Pharmaceuticals Corporation, a clinical stage biopharmaceutical company focused on the development and commercialization of improved treatments for neurodegenerative disorders. From 2008 through 2015, Mr. Giacobello held senior level finance positions at Allergan, Inc., most recently serving as Vice President of Finance for Global Research & Development. While at Allergan, he also served as Vice President of Corporate Finance and Vice President of Internal Audit & Compliance. Scott’s previous experience includes financial positions at the Black & Decker Corporation and Ernst & Young, LLP. Mr. Giacobello holds a bachelor’s degree in business administration from the University of Notre Dame and is a Certified Public Accountant.
Follow Scott Giacobello:
About GW Pharmaceuticals: GW Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics.
John Borgeson
Chief Financial Officer of ALX Oncology
John Borgeson is our Chief Financial Officer and has served in this position since June 2014. Borgeson brings over 25 years of pharmaceutical industry experience in finance, strategy and operations on a global scale. Previously Borgeson was a Vice President of Finance at Pfizer and a member of Pfizer’s Global Financial Leadership Team. Borgeson’s roles at Pfizer included CFO for Pfizer’s biotherapeutics division and corporate tax executive with responsibility for US and Europe. Under Borgeson’s leadership, Pfizer completed a transformational restructuring of the global tax group that was replicated by other Fortune 50 companies. Borgeson has more recently led finance for a variety of private biotech companies, including Labrys Biologics, which was acquired by Teva Pharmaceuticals for $825 million. He was also CFO of venBio, a venture capital firm with a strong track record in biotechnology investing. Borgeson started his career as an auditor with Ernst & Young and is a certified public accountant. He has an M.B.A. from R.I.T. and an undergraduate degree from the School of Management at the University at Buffalo (S.U.N.Y.).
Follow John Borgeson:
About ALX Oncology, Kodiak Sciences: ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Anthony M. Rimac
Chief Financial Officer of Cognoa
Follow Anthony M. Rimac:
About Cognoa: Cognoa is a behavioral health company focused on improving the lives and outcomes of children and families living with behavioral conditions
Mike Johnson
CFO of Cord Blood Registry
Mike Johnson joined CBR as CFO in January 2013. Mike was most recently the CFO of Fenwal, a global blood technology company dedicated to supporting transfusion medicine and cell therapies. He successfully managed a carve-out of the Fenwal business from Baxter in 2006. From 2006 to 2012 he led the global finance and IT organizations through a business transformation that supported international integration of a stand-alone business and resulted in significant value creation. TPG, a large private equity firm, recently sold the business to Fresenius. Prior to Fenwal, he spent almost 10 years in senior financial roles at Dade Behring, a leading medical diagnostics company, including Corporate Controller, and V.P. Finance for the manufacturing, supply chain and R&D organizations. Mike has a B.S. in Accounting from the University of Illinois and an M.B.A. from the University of Chicago.
Follow Mike Johnson:
About Cord Blood Registry: Cord Blood Registry is the world’s largest newborn stem cell company.
Sid Hartman
Chief Financial and Operating Officer of Marin Community Foundation
Sid joined the Foundation in 1997 as Vice President for Finance and Administration and in 2008 assumed his current position. For the prior 11 years, Sid was Vice President, Finance and Administration at the Minneapolis Foundation. He has also held various positions, including executive director, at the Challenge Center in Wisconsin, which served developmentally disabled adults and infants. He graduated from the University of Wisconsin.
Follow Sid Hartman:
About Marin Community Foundation: The Marin Community Foundation helps people make their charitable giving more effective and more personally satisfying.
Beth Gray
CFO of Cogitativo
Beth Gray has been serving as vice-president of finance of Cogitativo since January 2018.
Follow Beth Gray:
About Cogitativo: Cogitativo is a machine learning enterprise offering world class solutions to hospitals, physicians, and payers.
Jeff Mack
CFO of Potrero Medical
Follow Jeff Mack:
About Potrero Medical: Potrero Medical is a predictive health company that is developing the next generation of smart sensors and artificial intelligence.
Brandon Poe
Chief Financial Officer of Jumpcode Genomics
Brandon Poe is the Chief Financial Officer at Jumpcode Genomics.
Follow Brandon Poe:
About Jumpcode Genomics: JUMPCODE’s CRISPR-mediated rRNA depletion kits remove nucleic acids from sequencing workflows to improve sensitivity and performance.
Greg Curhan
Chief Financial Officer and SVP of Corporate Development of Providence Medical Technology
Greg is an experienced corporate executive and entrepreneur, as well as a capital markets and strategic advisory expert. He brings over 30 years of experience leading and advising fast-growing companies in the medical and information technology sectors to Providence. Greg has served as Chief Financial Officer of both public and private companies. Prior to joining Providence Medical Technology Greg Curhan served as a founder and past President of Merriman Curhan Ford, a leading San Francisco-based investment bank that supported venture-backed, high-growth companies in Silicon Valley, raised over $5 billion dollars for its corporate clients and advised on numerous mergers and acquisitions. Greg is a graduate of Dartmouth College where he earned a BA in Economics and graduated Summa Cum Laude.
Follow Greg Curhan:
About Providence Medical Technology: Providence Medical Technology is a privately-held medical device company focused on innovative solutions for cervical spinal conditions.
Susan Del Bene
Chief Financial Officer of Satellite Healthcare
Susan Del Bene joined Satellite Healthcare in 2003. She is responsible for the financial and accounting operations and for many of the administrative requirements of the organization. As a member of the executive management team, she is actively involved in the strategic and tactical planning and ongoing business development. Previously, Ms. Del Bene was the Chief Financial Officer for the CRC Health Corporation of San Jose, Calif., and the Chief Financial Officer for the CEDU Family of Services in Monterey, Calif. She also worked for Kaiser Permanente as the Controller at the San Francisco hospital. In addition to her experience in healthcare, she was a systems consultant with American Management Systems in various industries. Ms. Del Bene is a CPA, holds a B.S. in Accounting and has completed master’s work in information systems at Regis University and in taxation at Golden Gate University.
Follow Susan Del Bene:
About Satellite Healthcare: Satellite Healthcare is a not-for-profit dialysis provider focusing on patient-centered dialysis and kidney disease services.
Kamal Adawi
Chief Financial Officer of Exagen
Follow Kamal Adawi:
About Exagen: Exagen is a patient focused, discovery-driven life science company serving patients affected by autoimmune rheumatic diseases.
Patrick F. Williams
Chief Financial Officer of STAAR Surgical Company
Patrick F. Williams has served as Senior Vice President and Chief Financial Officer since November 2012. Mr. Williams has nearly 20 years of financial management experience. He spent more than 5 years at NuVasive, most recently as Vice President of Strategy and Investor relations and previously as Vice President of Finance and Investor Relations. In his most recent position, he worked directly with the company’s Chief Executive Officer and senior management to develop the company’s long-term growth and operational strategy while ensuring alignment across the organization. In his previous role, Mr. Williams was responsible for the day-to-day operations of the finance department including developing the worldwide budget and forecast, identifying profitability improvements, and predicting necessary infrastructure changes to support top-line growth and operating margins. He has had responsibility for managing all aspects of NuVasive’s investor relations efforts as well as significant government affairs duties. Prior to NuVasive, Mr. Williams served as Director of Financial Planning and Analysis at Callaway Golf, where he managed the day-to-day operations of the finance department including budgeting and forecasting, companywide operational analysis and financial reporting. Prior to Callaway, he held senior finance positions at Kyocera Wireless. Mr. Williams holds an MBA in Finance and Management from San Diego State University and a Bachelor of Arts in Economics from University of California, San Diego. – See more at: http://www.coolsculpting.com/company-info/our-team#sthash.ktAIPlmR.T0uU9n32.dpuf
Follow Patrick F. Williams:
About STAAR Surgical Company: STAAR Surgical Company is at the vanguard of minimally invasive ophthalmic vision enhancement and technology.
David Larson
CFO of True Diagnostics
David Larson is CFO at True Diagnostics.
Follow David Larson:
About True Diagnostics: True Diagnostics is a research, development, and manufacturing company specialized in immunodiagnostic test systems.
Ronald Jabba
CEO, Acting CFO of ProMed
Mr. Ronald Jabba serves as a Chief Executive Officer and Director at ProMed Inc.
Follow Ronald Jabba:
About ProMed, Zenflow: ProMed provides billing, credentialing, and contracting services in the healthcare sector.
John Packwood
Chief Financial Officer of People’s Care
Follow John Packwood:
About People’s Care: Since 1998, People’s Care has been working to ensure the best quality of life for individuals with developmental disabilities.
Lindsey Newton
Advisory CFO of Prescribe Nutrition
Follow Lindsey Newton:
About : Prescribe Nutrition offers a revolutionary, on demand approach to nutrition and wellness counseling.
David Olson
CFO of Heads Up Health
David Olson is a CFO at Heads Up Health.
Follow David Olson:
About Heads Up Health: Heads Up Health help individuals, sports teams and healthcare professionals make better decisions using data.
Mark Kaufmann
Chief Financial Officer & Chief Business Officer of ESCAPE Bio
Mr. Kaufmann has been a biotech executive with leadership experience as a CEO, CBO, COO and CFO at prior companies. Most recently he was the Chief Financial Officer and Head of Corporate Development at Ardelyx, Inc (ARDX), where he led the IPO and subsequently raised over $500 million in equity financings and completed $1.0 billion of licensing deals during his tenure. Previously he spent over a decade forming and leading multiple biotech companies in Montreal. He started his career at MedImmune, Inc.
Follow Mark Kaufmann:
About ESCAPE Bio: ESCAPE Bio is a clinical-stage biopharmaceutical company that develops small molecule drugs intended to treat neurodegenerative diseases.
Sarita Evans
Co-Founder and CFO of Spectrum CannaLabs
Sarita Evans is the co-founder and CFO of Spectrum CannaLabs.
Follow Sarita Evans:
About Spectrum CannaLabs: Spectrum CannaLabs is an analytical testing laboratory that provides testing solutions for legal cannabis products.
Trisha Millican
CFO of Metacrine
Follow Trisha Millican:
About Metacrine: Metacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs.
David Mahoney
Chief Financial Officer of Medical Anesthesia Consultants
David Mahoney joined MAC in 2004 and has served as MAC’s Chief Financial Officer, Secretary, and Chair of the Audit Committee since 2008. He has served on the MAC Board of Directors/Management Committee since 2008. Dr. Mahoney received his M.D. at the University of Wisconsin – Madison and completed his anesthesia residency at the University of Michigan – Ann Arbor.
Follow David Mahoney:
About Medical Anesthesia Consultants: Medical Anesthesia Consultants provides perioperative care to hospitals, medical centers, surgery centers, and physicians’ offices.